Communication is at the heart of GatewayC and fundamental to improving patient care. This series focuses on introductions and reflections from the team behind the programme. In this post, we’re introducing GatewayC's Data Analyst, Thomas Bailey. Could...
World Pancreatic Awareness Day
Latest from the Blog
Access GatewayC’s Ovarian Cancer – Early Diagnosis course
Friday 11th December 2020 We are delighted to announce that the new Ovarian Cancer - Early Diagnosis course is now available on GatewayC. Ovarian cancer is the sixth most common cancer for women in the UK, with around 7,400 diagnoses each year. Most women are...
Related Posts
Access GatewayC’s Ovarian Cancer – Early Diagnosis course
Friday 11th December 2020 We are delighted to announce that the new Ovarian Cancer - Early Diagnosis course is now available on GatewayC. Ovarian cancer is the sixth most common cancer for women in the UK, with around 7,400 diagnoses each year. Most women are...
Meet the specialists: improving early diagnosis Q&A
Friday 27th November 2020 Missed our free GatewayC webinar on Improving Early Diagnosis? Watch our recording here. In this webinar, GatewayC met Dr Anthony Cunliffe, Joint National Lead Macmillan GP Adviser, and Dr Ben Noble, East Midlands Cancer Alliance and Cancer...

Thursday 19th November 2020
Today is World Pancreatic Awareness Day 2020.
Why not increase your knowledge and complete our free online Pancreatic Cancer – Early Diagnosis course and collect 2 CPD hours?
In the early stages of the disease, pancreatic cancer may not cause any signs or symptoms. Moreover, symptoms can be non-specific and may fluctuate in presentation.
Our course will support you to:
- Recognise a number of, often vague, symptoms that can be associated with pancreatic cancer
- Consider the significance of sudden onset diabetes in patients for whom this would be unexpected
- Confidently assess the need for referral in accordance with NICE NG12 guidelines
Our course includes a full interview with Consultant Surgeon, Mr. Derek O’Reilly, which explores new-onset diabetes and pancreatic cancer diagnoses.
Find out more: